Market
Highlights
The
global antidiuretic drugs market is expected to show sharp growth over the
forecast period. Increasing prevalence of diabetes and demand for new drugs for
its treatment are the key factor for the market growth. Rising geriatric
population with diabetes insipidus also drive the market growth. Also, use of
antidiuretic drugs for the treatment of hypertension is found to be increasing
across the globe.
The
global antidiuretic drugs market is expected to grow at a CAGR of 9.7% during
the forecast period and is estimated to reach USD 180 million by 2023.
Taste
the market data and market information presented through more than 120 market
data tables and figures spread over 200 pages of the project report. Avail the
in-depth table of content TOC & market synopsis on “Antidiuretic drugs
market research report–Global forecast till 2023.”
Request For Sample Report: https://www.marketresearchfuture.com/sample_request/4306
Major
Players in Antidiuretic drugs Market
Some
of the key players in the global market are Par Sterile Products, LLC
(U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva
Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj
Pharmaceuticals Limited (India) and ALLERGAN (U.S.).
Regional
Analysis
The global antidiuretic drugs market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The global antidiuretic drugs market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate
the global antidiuretic drugs market. It comprises of two regions namely North
America and South America. The market in the American region is driven by the
rising prevalence of diabetes insipidus. Increase in geriatric population with
diabetes and hypertension also contribute to the market growth.
In Europe, increasing
adoption of new drugs for the treatment of diabetes insipidus, and availability
of funds for research and development.
Asia Pacific is the
fastest growing and potential market for the antidiuretic drugs treatment,
whose growth is attributed to the increase in the awareness about the use of
antidiuretics for the treatment and its side effects. Expansion of healthcare
system in developing countries in Asia Pacific also favors the market growth.
The Middle East &
Africa is expected to witness steady growth due to rising demand for primary
healthcare services.
Segmentation
The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
No comments:
Post a Comment